Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-26-001262
Filing Date
2026-02-17
Accepted
2026-02-17 21:53:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8775
  Complete submission text file 0001172661-26-001262.txt   10446
Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Subject) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94343 | Film No.: 26645124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)